Rare lephants
Screener

PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 10, 2023
SC 13G/A Feb 10, 2023 SC 13G/A
4 Feb 9, 2023 PRIMARY DOCUMENT
4 Feb 9, 2023 PRIMARY DOCUMENT
4 Feb 9, 2023 PRIMARY DOCUMENT
4 Feb 9, 2023 PRIMARY DOCUMENT
4 Feb 9, 2023 PRIMARY DOCUMENT
SC 13G/A Feb 9, 2023
8-K Jan 23, 2023 8-K
8-K Jan 9, 2023 8-K
4 Dec 22, 2022 PRIMARY DOCUMENT
4 Dec 21, 2022 PRIMARY DOCUMENT
4 Dec 12, 2022 PRIMARY DOCUMENT
10-Q Nov 14, 2022 10-Q
8-K Nov 14, 2022 8-K
10-Q Aug 9, 2022 10-Q
8-K Aug 9, 2022 8-K
4 Jun 22, 2022 PRIMARY DOCUMENT
4 Jun 22, 2022 PRIMARY DOCUMENT
4 Jun 22, 2022 PRIMARY DOCUMENT
4 Jun 22, 2022 PRIMARY DOCUMENT
4 Jun 22, 2022 PRIMARY DOCUMENT
4 Jun 22, 2022 FORM 4 SUBMISSION
8-K Jun 21, 2022 8-K
4 Jun 1, 2022 PRIMARY DOCUMENT
← Newer Page 9 of 16 · 389 filings Older →